A5 Template Masters

Brochure Title Here
2. Medical products and medical
devices - An overview of their
regulation in Europe
An overview of their regulation in Europe
Under European legislation, a medicinal product is defined as any substance
or combination of substances presented for treating or preventing disease
in human beings. This includes combinations of substances that may be
administered to human beings to make a medical diagnosis or to restore,
correct or modify their physiological functions.
We also acted on the first reported
case of HMRC using Schedule 36 of
the Finance Act 2008 to btain
In the landmark case of Pyrrho
Investments v MWB Property & Ors
[ 2016 ] EWHC 256 (Ch), the team
obtained the English court’s first
express approval of the use of
Predictive Coding in disclosure – in
which the court recognised the
significant time and costs benefits
that could be gained from using
this technology
We have partnered with an AI
start-up (LitiGate) to assist with
their product development which
seeks to streamline and optimise
legal research, initially in relation
to interim applications
Ed Spencer, one of our Senior
Associates, is heavily involved with
Relativity (formerly kCura) in both
London and Chicago regularly
participating in user development
workshops and product feedback
sessions. He is a regular speaker
at eDisclosure and information
governance conferences around
the world where he presents on the
latest igations.
2. Medicinal products
and medical devices
An overview of their regulation in Europe
We also acted on the first reported
case of HMRC using Schedule 36 of
the Finance Act 2008 to btain
In the landmark case of Pyrrho
Investments v MWB Property & Ors
[ 2016 ] EWHC 256 (Ch), the team
obtained the English court’s first
express approval of the use of
Predictive Coding in disclosure – in
which the court recognised the
significant time and costs benefits
that could be gained from using
this technology
We have partnered with an AI
start-up (LitiGate) to assist with
Chapter Title
Under European legislation, a medicinal product is defined as any substance
or combination of substances presented for treating or preventing disease
in human beings. This includes combinations of substances that may be
administered to human beings to make a medical diagnosis or to restore,
correct or modify their physiological functions.
their product development which
seeks to streamline and optimise
legal research, initially in relation
to interim applications
Ed Spencer, one of our Senior
Associates, is heavily involved with
Relativity (formerly kCura) in both
London and Chicago regularly
participating in user development
workshops and product feedback
sessions. He is a regular speaker
at eDisclosure and information
governance conferences around
the world where he presents on the
latest igations.
23
24